サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1624409

細胞分析の世界市場規模：製品タイプ別、細胞タイプ別、エンドユーザー別、地域別、範囲および予測

Global Cell Analysis Market Size By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells, Microbial Cells), By End-User (Biotechnology Companies, Hospitals, Cell Banks), By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
細胞分析の世界市場規模：製品タイプ別、細胞タイプ別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年11月18日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細胞分析の市場規模と予測

細胞分析市場規模は、2021年に160億7,000万米ドルと評価され、2023年から2030年にかけて10.15%のCAGRで成長し、2030年には383億4,000万米ドルに達すると予測されています。細胞ベースの研究に対する政府資金の増加は、市場成長を促進する単一細胞分析製品の技術的進歩だけでなく、細胞分析の市場収益増加の重要な側面です。細胞分析の世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の細胞分析市場の定義

細胞分析は、単一細胞レベルで生物のゲノム、メタボロミクス、トランスクリプトミクス、プロテオミクスを研究します。単一細胞分析は、ヒトゲノムを単一細胞の不均一性で測定、分析、配列決定する際に使用されます。蛍光活性化セルソーティングは、複雑なサンプルから選択された単一細胞を分離します。臨床診断において、細胞解析は、がんのリアルタイムモニタリングのための貴重な情報、そして最終的には患者の利益のための新たな治療戦略のために、ワークフローを標準化し、自動化することが期待されています。

細胞分析は、遺伝子同定、タンパク質同定、エピゲノミクス、その他のライフサイエンス関連分野で不可欠です。細胞イメージングと分析システムの精度向上は、創薬プロセスの時間短縮と価格低減に役立ちます。今日、ほとんどの場所で、細胞は1サンプルあたり数千の細胞で大量に分析され、結果は細胞の平均的な反応に基づいて分析されます。したがって、実用的で正確な細胞分析を行うには、個々の細胞が正確にどのように反応するかを検討することが不可欠です。

世界の細胞分析市場概要

細胞分析市場の発展は、ヘルスケア産業の発展とがん罹患率の上昇が原動力となっています。さらに、技術的に先進的な製品のイントロダクションや病院、診断研究所などの増加が市場成長を後押ししています。さらに、診断アプリケーションへの細胞分析の採用が増加していることも、世界の細胞分析市場の開拓を促進する重要な要因となっています。さらに、細胞ベースの研究に対する政府の投資と資金調達の増加は、世界市場の成長を促進する他の要因です。

さらに、感染症や慢性疾患、神経疾患の有病率の増加は、細胞分析の世界市場の成長を促進するポジティブな予測となっています。市場全体の成長を阻害する課題もあります。機器のコストが高いなどの要因が市場の成長を阻害しています。また、小規模企業や新規参入企業の生き残りも、市場が直面する大きな課題です。しかし、体細胞研究と細胞シーケンシングの研究開発は、世界の細胞分析市場内の主要プレーヤーに有利なビジネスチャンスをもたらすと期待されます。

目次

第1章 世界の細胞分析市場のイントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の細胞分析市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 規制の枠組み

第5章 細胞分析の世界市場：製品別

  • 概要
  • 消耗品
    • 試薬
    • アッセイキット
    • マイクロプレート
    • その他
  • 検査機器
    • 顕微鏡
    • フローサイトメトリー
    • 分光光度計
    • qPCR
    • セルカウンター
    • HCSシステム
    • 細胞マイクロアレイ

第6章 世界の細胞分析市場：細胞タイプ別

  • 概要
  • ヒト細胞
  • 動物細胞
  • 微生物細胞

第7章 世界の細胞分析市場：エンドユーザー別

  • 概要
  • バイオテクノロジー企業
  • 病院
  • 細胞バンク
  • その他

第8章 細胞分析の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 世界のその他の地域
    • 中東・アフリカ

第9章 世界の細胞分析市場の競合情勢

  • 概要
  • 企業市場シェア
  • ベンダー情勢
  • 主な発展戦略

第10章 企業プロファイル

  • Becton, Dickinson and Company
  • Merck KGAA
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Agilent Technologies, Inc.
  • Olympus Corporation
  • Perkinelmer, Inc.
  • Promega Corporation
  • Tecan Group Ltd.

第11章 主な発展

  • 製品の上市／開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

  • 関連調査
目次
Product Code: 24214

Cell Analysis Market Size And Forecast

Cell Analysis Market size was valued at USD 16.07 Billion in 2021 and is projected to reach USD 38.34 Billion by 2030 , growing at a CAGR of 10.15% from 2023 to 2030. The increasing government funding for cell-based research is the crucial aspect of the rise in the market revenue of Cell Analysis as well as the technological advancements in single-cell analysis products that will foster market growth. The Global Cell Analysis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cell Analysis Market Definition

Cell Analysis studies the genomics, metabolomics, transcriptomics, and proteomics of a living being at a single-cell level. The single-Cell Analysis is used in measuring, analyzing, and sequencing the human genome at a single-cell heterogeneity. Fluorescence-activated cell sorting isolates the selected single cells from complex samples. In clinical diagnostics, Cell Analysis is expected to standardize and automate workflows with valuable information for real-time monitoring of cancer and, eventually, new therapeutic strategies for the benefit of patients.

Cellular Analysis is vital in gene identification, protein identification, epigenomics, and other life science-related areas. Enhanced accuracy of cell imaging and analysis systems helps reduce the drug discovery process time and price. Today in most places, cells are analyzed in masses with thousands of cells per sample, and results are analyzed based on the average response of the cells. Hence to get practical and accurate Cell Analysis, it's essential to review how exactly individual cells respond.

Global Cell Analysis Market Overview

The Growth of the Cell Analysis Market is driven by the development of the healthcare industry and the rise in cancer incidence. Furthermore, the introduction of technologically advanced products and an increased number of hospitals, diagnostic laboratories, and others fuel the market growth. Moreover, increasing the adoption of Cell Analysis for diagnostic applications is a significant factor driving the development of the global Cell Analysis Market. Moreover, rising government investments and funding for cell-based research are other factors fueling the growth of the worldwide market.

Moreover, the increasing prevalence of infectious & chronic diseases and neurological disorders has positively anticipated propelling the growth of the global Cell Analysis Market. There are specific challenges faced that will hinder the overall market growth. Factors such as the high cost of instruments inhibit the market's growth. Also, the survival of small players and new entrants is the major challenge faced by the market. However, research and development in somatic cell research and cell sequencing may be expected to present lucrative business opportunities for major players within the global Cell Analysis Market.

Global Cell Analysis Market Segmentation Analysis

The Global Cell Analysis Market is segmented based on Product, Cell Type, End-User, And Geography.

Cell Analysis Market, By Product

  • Consumables
  • Instruments

Based on Product, the market is bifurcated into Consumables and Instruments. The consumables segment holds the largest market share during the forecast period. The factors that can be attributed to the frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are accelerating the demand for consumables segment.

Cell Analysis Market, By Cell Type

  • Human Cells
  • Animal Cells
  • Microbial Cells

Based on Cell Type, the market is bifurcated into Human Cells, Animal Cells, and Microbial Cells. The human cells segment holds the largest market share. The factors that can be attributed to the high utilization of human cells in research laboratories and academic institutes are accelerating the demand.

Cell Analysis Market, By End-User

  • Biotechnology Companies
  • Hospitals
  • Cell Banks
  • Others

Based on End-User, the market is bifurcated into Biotechnology Companies, Hospitals, Cell Banks, and Others. The academic and research laboratories segment holds the largest market share during the forecast period. The factors that can be attributed to growth in funding for all times science research and therefore the increasing number of medical colleges and universities enhance the demand for academic and research laboratories segment.

Cell Analysis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of The World
  • On the basis of Geography, the Global Cell Analysis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific holds the largest market share. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, growth in the outsourcing of drug discovery services to Asian CROs, strong governmental initiatives, and ongoing projects will boost the market in the APAC region.

Key Players

  • The "Global Cell Analysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Becton, Dickinson and Company, Merck KGAA, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Agilent Technologies, Inc., Olympus Corporation, Perkinelmer, Inc., Promega Corporation, and Tecan Group Ltd.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Product Launches and Product Expansions
  • In April 2018, BD (Becton, Dickinson and Business), a leading worldwide medical technology company, announced the launch of the BD FACSymphony(TM) S6 cell sorter, which will be on exhibit at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform takes advantage of the BD FACSymphony cell analyzer's high parameter capabilities, allowing researchers to sort cell populations to better understand cell phenotypes for immunology and multi-omics research.
  • In May 2018, Beckman Coulter Life Sciences introduced the Kaluza C Flow Cytometry Analysis Software, a sophisticated data analysis system for clinical laboratories. The new program simplifies clinical QC reporting and addresses flow cytometry standardization difficulties.
  • In September 2018, Leica Microsystems established the first Imaging Center in San Francisco. This facility will showcase the spectrum of technology in microscopes produced by Leica Microsystems for life sciences research.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CELL ANALYSIS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CELL ANALYSIS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL CELL ANALYSIS MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Consumables
    • 5.2.1 Reagents
    • 5.2.2 Assay Kits
    • 5.2.2.1 Immuno assays
    • 5.2.2.2 Cell based assays
    • 5.2.3 Microplates
    • 5.2.4 Others
  • 5.3 Instruments
    • 5.3.1 Microscopes
    • 5.3.2 Flow cytometry
    • 5.3.3 Spectrophotometers
    • 5.3.4 qPCR
    • 5.3.5 Cell Counters
    • 5.3.6 HCS Systems
    • 5.3.7 Cell Microarrays

6 GLOBAL CELL ANALYSIS MARKET, BY CELL TYPE

  • 6.1 Overview
  • 6.2 Human Cells
  • 6.3 Animal Cells
  • 6.4 Microbial Cells

7 GLOBAL CELL ANALYSIS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Biotechnology Companies
  • 7.3 Hospitals
  • 7.4 Cell Banks
  • 7.5 Others

8 GLOBAL CELL ANALYSIS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
  • 8.6 Rest of the World
    • 8.6.1 Middle East and Africa

9 GLOBAL CELL ANALYSIS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Share
  • 9.3 Vendor Landscape
  • 9.4 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Becton, Dickinson and Company
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Merck KGAA
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Thermo Fisher Scientific, Inc.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Danaher Corporation
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 GE Healthcare
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Agilent Technologies, Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Olympus Corporation
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Perkinelmer, Inc.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Promega Corporation
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Tecan Group Ltd.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research